Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Arthritis and MTRR[original query] |
|---|
| Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis. Arthritis and rheumatism 2006 Sep 54 (9): 2830-9. Wessels Judith A M, Kooloos Wouter M, De Jonge Robert, De Vries-Bouwstra Jeska K, Allaart Cornelia F, Linssen Annelies, Collee Gerard, De Sonnaville Peter, Lindemans Jan, Huizinga Tom W J, Guchelaar Henk-J |
| Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. European journal of clinical pharmacology 2008 Nov 64 (11): 1057-68. Bohanec Grabar Petra, Logar Dusan, Lestan Boris, Dolzan Vi |
| Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate. Pharmacogenetics and genomics 2010 Jun 20 (6): 367-76. Stamp Lisa K, Chapman Peter T, O'Donnell John L, Zhang Mei, James Jill, Frampton Christopher, Barclay Murray L, Kennedy Martin A, Roberts Rebecca |
| Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis. Drug metabolism and pharmacokinetics 2012 27 (2): 192-9. Kato Tomomi, Hamada Akinobu, Mori Shunsuke, Saito Hideyu |
| Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway. European journal of drug metabolism and pharmacokinetics 2015 Jun . Chaabane Souhir, Marzouk Sameh, Akrout Rim, Ben Hamad Mariem, Achour Yosser, Rebai Ahmed, Keskes Leila, Fourati Hela, Bahloul Zouhir, Maalej Abdellat |
| Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome. Pharmacogenomics 2016 Sep . Lima Aurea, Bernardes Miguel, Azevedo Rita, Seabra Vitor, Medeiros R |
| Nonassociation of homocysteine gene polymorphisms with treatment outcome in South Indian Tamil Rheumatoid Arthritis patients. Clinical and experimental medicine 2017 Aug . Muralidharan Niveditha, Gulati Reena, Misra Durga Prasanna, Negi Vir |
| Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis. The Journal of rheumatology 2017 Jun . Zajc Avramovi? Mojca, Dolžan Vita, Toplak Nataša, Accetto Meta, Lusa Lara, Av?in Tad |
| Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis. Scientific reports 2017 Mar 7 44015. Qiu Qi, Huang Jing, Shu Xiaoming, Fan Huizheng, Zhou Youwen, Xiao Che |
| MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C Polymorphisms and Disease Activity in Mexicans with Rheumatoid Arthritis Treated with Methotrexate. Genetic testing and molecular biomarkers 2017 Oct . González-Mercado Mirna Gisel, Rivas Fernando, Gallegos-Arreola M Patricia, Morán-Moguel M Cristina, Salazar-Páramo Mario, González-López Laura, Gámez-Nava J Iván, Muñoz-Valle J Francisco, Medina-Coss Y León Ricardo, González-Mercado Anahí, Aceves Mario A, Dávalos Nory O, Macías-Chumacera Agustín, Dávalos Ingrid |
| Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis. Scientific reports 2018 May 8 (1): 7342. López-Rodríguez Rosario, Ferreiro-Iglesias Aida, Lima Aurea, Bernardes Miguel, Pawlik Andrzej, Paradowska-Gorycka Agnieszka, ?wierkot Jerzy, Slezak Ryszard, Dolžan Vita, González-Álvaro Isidoro, Narváez Javier, Cáliz Rafael, Pérez-Pampín Eva, Mera-Varela Antonio, Vidal-Bralo Laura, Acuña Ochoa José Gorgonio, Conde Carmen, Gómez-Reino Juan J, González Anton |
| Genetic Polymorphisms of TYMS, MTHFR, ATIC, MTR, and MTRR Are Related to the Outcome of Methotrexate Therapy for Rheumatoid Arthritis in a Chinese Population. Frontiers in pharmacology 2018 9 1390. Lv Shuang, Fan HuiZhen, Li Jiang, Yang Hui, Huang Jing, Shu XiaoMing, Zhang Lu, Xu Yuan, Li Xiaoya, Zuo Jieyu, Xiao Che |
| Identification of SNPs associated with methotrexate treatment outcomes in patients with early rheumatoid arthritis. Frontiers in pharmacology 2022 12 13 1075603. Kolan Shrikant S, Li Gaoyang, Grimolizzi Franco, Sexton Joe, Goll Guro, Kvien Tore K, Sundlisæter Nina Paulshus, Zucknick Manuela, Lillegraven Siri, Haavardsholm Espen A, Skålhegg Bjørn Ste |
| The impact of single nucleotide polymorphisms in MTHFR and MTRR genes on disease activity and the presence of methotrexate treatment side effects in children with juvenile idiopathic arthritis. Archives of medical science : AMS 2023 6 19 (3): 810-813. Justyna Roszkiewicz, Dominika Micha?ek, Aleksandra Ryk, Bartosz Szmyd, El?bieta Smolews |
| MTHFR and MTRR Genetic Polymorphism of Methotrexate Therapy Outcomes in Early Rheumatoid Arthritis. Pharmacogenomics and personalized medicine 2023 5 16 407-423. Qian Zhang, Pan Fu, Zhanglei Cao, Hua Huang, Qinwen Wen, Kaizhe Wang, Tong Kong, Xiudi Wu, Jianping Zhe |
- Page last reviewed:Feb 1, 2024
- Content source: